164 related articles for article (PubMed ID: 19968886)
21. ZCCHC12, a potential molecular marker of papillary thyroid carcinoma: a preliminary study.
Li QL; Chen FJ; Lai R; Guo ZM; Luo R; Yang AK
Med Oncol; 2012 Sep; 29(3):1409-17. PubMed ID: 21739307
[TBL] [Abstract][Full Text] [Related]
22. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles.
Huang Y; Prasad M; Lemon WJ; Hampel H; Wright FA; Kornacker K; LiVolsi V; Frankel W; Kloos RT; Eng C; Pellegata NS; de la Chapelle A
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15044-9. PubMed ID: 11752453
[TBL] [Abstract][Full Text] [Related]
23. High expression of claudin-1 protein in papillary thyroid tumor and its regional lymph node metastasis.
Németh J; Németh Z; Tátrai P; Péter I; Somorácz A; Szász AM; Kiss A; Schaff Z
Pathol Oncol Res; 2010 Mar; 16(1):19-27. PubMed ID: 19578981
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
Wasenius VM; Hemmer S; Kettunen E; Knuutila S; Franssila K; Joensuu H
Clin Cancer Res; 2003 Jan; 9(1):68-75. PubMed ID: 12538453
[TBL] [Abstract][Full Text] [Related]
26. Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes.
Aldred MA; Huang Y; Liyanarachchi S; Pellegata NS; Gimm O; Jhiang S; Davuluri RV; de la Chapelle A; Eng C
J Clin Oncol; 2004 Sep; 22(17):3531-9. PubMed ID: 15337802
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling of papillary thyroid carcinomas in Korean patients by oligonucleotide microarrays.
Chung KW; Kim SW; Kim SW
J Korean Surg Soc; 2012 May; 82(5):271-80. PubMed ID: 22563533
[TBL] [Abstract][Full Text] [Related]
28. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.
Giannini R; Faviana P; Cavinato T; Elisei R; Pacini F; Berti P; Fontanini G; Ugolini C; Camacci T; De Ieso K; Miccoli P; Pinchera A; Basolo F
Thyroid; 2003 Aug; 13(8):765-70. PubMed ID: 14558920
[TBL] [Abstract][Full Text] [Related]
29. An aberrant autocrine activation of the platelet-derived growth factor alpha-receptor in follicular and papillary thyroid carcinoma cell lines.
Chen KT; Lin JD; Liou MJ; Weng HF; Chang CA; Chan EC
Cancer Lett; 2006 Jan; 231(2):192-205. PubMed ID: 16126335
[TBL] [Abstract][Full Text] [Related]
30. Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors alpha and beta in activated rat hepatic stellate cells (HSC).
Breitkopf K; Roeyen Cv; Sawitza I; Wickert L; Floege J; Gressner AM
Cytokine; 2005 Sep; 31(5):349-57. PubMed ID: 16039137
[TBL] [Abstract][Full Text] [Related]
31. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies.
Muzza M; Degl'Innocenti D; Colombo C; Perrino M; Ravasi E; Rossi S; Cirello V; Beck-Peccoz P; Borrello MG; Fugazzola L
Clin Endocrinol (Oxf); 2010 May; 72(5):702-8. PubMed ID: 20447069
[TBL] [Abstract][Full Text] [Related]
32.
Tanaka A; Matsuse M; Saenko V; Nakao T; Yamanouchi K; Sakimura C; Yano H; Nishihara E; Hirokawa M; Suzuki K; Miyauchi A; Eguchi S; Yoshiura KI; Yamashita S; Nagayasu T; Mitsutake N
Thyroid; 2019 Aug; 29(8):1105-1114. PubMed ID: 31286848
[No Abstract] [Full Text] [Related]
33. High periostin expression correlates with aggressiveness in papillary thyroid carcinomas.
Puppin C; Fabbro D; Dima M; Di Loreto C; Puxeddu E; Filetti S; Russo D; Damante G
J Endocrinol; 2008 May; 197(2):401-8. PubMed ID: 18434370
[TBL] [Abstract][Full Text] [Related]
34. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.
Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R
Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273
[TBL] [Abstract][Full Text] [Related]
35. High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma.
Tang C; Yang L; Wang N; Li L; Xu M; Chen GG; Liu ZM
Int J Clin Exp Pathol; 2014; 7(6):3213-23. PubMed ID: 25031742
[TBL] [Abstract][Full Text] [Related]
36. Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.
Wang Y; Hardin H; Chu YH; Esbona K; Zhang R; Lloyd RV
Endocr Pathol; 2019 Dec; 30(4):262-269. PubMed ID: 31468286
[TBL] [Abstract][Full Text] [Related]
37. NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas.
Górka B; Skubis-Zegadło J; Mikula M; Bardadin K; Paliczka E; Czarnocka B
Br J Cancer; 2007 Aug; 97(4):531-8. PubMed ID: 17667921
[TBL] [Abstract][Full Text] [Related]
38. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
39. Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas.
Rodrigues R; Roque L; Espadinha C; Pinto A; Domingues R; Dinis J; Catarino A; Pereira T; Leite V
Oncol Rep; 2007 Oct; 18(4):917-26. PubMed ID: 17786355
[TBL] [Abstract][Full Text] [Related]
40. Deregulated expression of VHL mRNA variants in papillary thyroid cancer.
Baldini E; Tuccilli C; Arlot-Bonnemains Y; Chesnel F; Sorrenti S; De Vito C; Catania A; D'Armiento E; Antonelli A; Fallahi P; Watutantrige-Fernando S; Tartaglia F; Barollo S; Mian C; Bononi M; Arceri S; Mascagni D; Vergine M; Pironi D; Monti M; Filippini A; Ulisse S
Mol Cell Endocrinol; 2017 Mar; 443():121-127. PubMed ID: 28089820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
